FDA
approval
· 2016-03-22
FDA Approved: LEVALBUTEROL — Original Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approves Mylan's original ANDA for levalbuterol hydrochloride, a generic inhaled bronchodilator indicated for reversible obstructive airway disease such as …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LEVALBUTEROL (LEVALBUTEROL)